Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2003
03/13/2003WO2003020958A2 Campylobacter typing
03/13/2003WO2003020954A2 205p1b5 in treatment and detection of cancer
03/13/2003WO2003020952A2 Affinity-shifted probes for quantifying analyte polynucleotides
03/13/2003WO2003020948A2 Fret protease assays for botulinum serotype a/e toxins
03/13/2003WO2003020947A2 Mid 9002, a human sulfatase family member and uses therefor
03/13/2003WO2003020934A1 Compositions and methods relating to colon specific genes and proteins
03/13/2003WO2003020933A1 Novel serine protease inhibitory protein mt0039
03/13/2003WO2003020930A1 IDENTIFICATION AND USE OF MAMMALIAN p21 INHIBITORS
03/13/2003WO2003020909A2 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders
03/13/2003WO2003020902A2 Methods for blocking nonspecific hybridizations of nucleic acid sequences
03/13/2003WO2003020901A2 Compositions and methods relating to prostate specific genes and proteins
03/13/2003WO2003020892A2 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY
03/13/2003WO2003020891A2 Single nucleotide amplification and detection by polymerase
03/13/2003WO2003020890A2 Genes encoding baeyer-villiger monooxygenases
03/13/2003WO2003020889A2 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
03/13/2003WO2003020887A2 Gene identification
03/13/2003WO2003020886A2 Methods and devices for detecting cell-cell interactions
03/13/2003WO2003020883A2 Nuclear bodies
03/13/2003WO2003020881A2 DOMINANT NEGATIVE VARIANTS OF METHIONINE AMINOPEPTIDASE 2 (MetAP2) AND CLINICAL USES THEREOF
03/13/2003WO2003020878A2 Amplification and detection reagents for hiv-1
03/13/2003WO2003020873A2 Reproduction of ribonucleic acids
03/13/2003WO2003020769A1 Pemphigus monoclonal antibody
03/13/2003WO2003020763A2 Soluble t cell receptor
03/13/2003WO2003020762A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
03/13/2003WO2003020759A2 A caspase- 8 binding protein, its preparation and use
03/13/2003WO2003020739A2 Novel lna compositions and uses thereof
03/13/2003WO2003020734A2 Labeled nucleoside polyphosphates
03/13/2003WO2003020702A2 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
03/13/2003WO2003020425A1 Multi-layer coated porous materials and methods of making the same
03/13/2003WO2003020424A1 Device for use in fluid assay
03/13/2003WO2003020415A2 Treatment of substrates using an electrochemical method
03/13/2003WO2003020307A1 Bone morphogenic protein 2-induced genes and polypeptides, and their use in diagnostic and therapeutic methods
03/13/2003WO2003020220A2 Mitochondrial biology expression arrays
03/13/2003WO2003020204A2 Detection of bovine viral diarrhea virus in tissue samples
03/13/2003WO2003020133A2 Method for determining the viscosity of an adulterated blood sample over plural shear rates
03/13/2003WO2003020123A2 Conjunctive analysis of biological marker expression for diagnosing organ failure
03/13/2003WO2003020118A2 Diagnosis and treatment of vascular disease
03/13/2003WO2003020115A2 Methods and compositions for the detection of cancer
03/13/2003WO2003020013A1 Plant-derived resistance gene
03/13/2003WO2002099038A3 Adsls as modifiers of the p53 pathway and methods of use
03/13/2003WO2002098199A3 Method and system for marking and determining the authenticity of liquid hydrocarbons
03/13/2003WO2002090930A3 Stabilizing peroxides with stannous halides
03/13/2003WO2002085932A3 Constructs and methods for expression of recombinant hcv envelope proteins
03/13/2003WO2002082051A3 An integrated high throughput system for the analysis of biomolecules
03/13/2003WO2002077636A3 Volatile signature detector and associated methods
03/13/2003WO2002077217A3 Human dual specificity protein phosphatase 7-like protein
03/13/2003WO2002074979A3 Expression profiles and methods of use
03/13/2003WO2002074976A3 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
03/13/2003WO2002073209A3 Method for identifying immune reactive epitopes on proteins
03/13/2003WO2002071928A3 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
03/13/2003WO2002067760A3 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
03/13/2003WO2002064629A3 Isolated human transporter proteins, nucleic acid molecules encoding them and uses thereof
03/13/2003WO2002063304A3 Sample support for chemical and biological samples
03/13/2003WO2002063012A3 Ragweed allergens
03/13/2003WO2002061084A3 Nt69, a nucleoside transporter family member and uses therefor
03/13/2003WO2002061038A3 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
03/13/2003WO2002059615A3 Method for detection of the presence of prion proteins
03/13/2003WO2002059600A3 Analyte detection
03/13/2003WO2002057789A3 Test for transmissible spongiform encephalopathies
03/13/2003WO2002057784A3 Chlamydia heat shock protein
03/13/2003WO2002057779A3 Cloning and expression of a new mcp receptor in glial cells
03/13/2003WO2002057745A3 Dendritic chemiluminescent substrates
03/13/2003WO2002052270A3 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
03/13/2003WO2002052042A3 Method for assaying compounds
03/13/2003WO2002050560A3 Method for determination of the origin and authenticity of materials with biological biochemical and nutritional physiological relevance by measurement of relative positional relationships for oxygen and hydrogen isotopes
03/13/2003WO2002050512A3 Method of characterizing potential therapeutics by determining cell-cell interactions
03/13/2003WO2002050286A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
03/13/2003WO2002048363A3 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
03/13/2003WO2002046461A3 Method for identifying modulators of transcription
03/13/2003WO2002046407A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/13/2003WO2002044720A3 Membrane molecule indicator compositions and methods
03/13/2003WO2002044380A3 Master bone formation transcription factor: compositions and methods of use
03/13/2003WO2002044379A3 Transforming growth factor-beta-related molecules and uses thereof
03/13/2003WO2002042456A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/13/2003WO2002042332A3 Truncated cd200
03/13/2003WO2002040530A3 Mutant bcl-2 proteins and uses thereof
03/13/2003WO2002039990A3 Method for screening anti-proliferative compounds and inhibiting tumor growth
03/13/2003WO2002039126A3 Stable, reliable capacitive oil deterioration and level sensor
03/13/2003WO2002039114A3 Improved assay and reagents or immunological determination of analyte concentration
03/13/2003WO2002039110A3 A method for the quantification of carbohydrates
03/13/2003WO2002038608A3 Methods of screening for ltrpc2 modulators
03/13/2003WO2002036829A3 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries
03/13/2003WO2002034916A3 Novel mutant igbp-3 molecules that do not bind to igfs, but retain their ability to functionally bind igfbp-3 receptor
03/13/2003WO2002032936A3 E. histolytica-specific antibodies and clinical uses thereof
03/13/2003WO2002031515A3 Xenogeneic antibody containing plasma reagents and associated methods
03/13/2003WO2002031511A3 Modulation of ligand binding/enzymatic activity of alpha beta proteins
03/13/2003WO2002031186A3 Method for the detection of cytosine methylations
03/13/2003WO2002030391A3 Method for determining the release of a peptide from a sustained release polylactide formulation
03/13/2003WO2002029503A3 Flexible protocol generator
03/13/2003WO2002026984A3 Potassium channel interactors and uses therefor
03/13/2003WO2002026822A3 Pumpcn compositions and uses thereof
03/13/2003WO2002025287A8 Detection of peptides
03/13/2003WO2002024946A3 Quadruplex dna and duplex probe systems
03/13/2003WO2002024920A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/13/2003WO2002024177A3 Methods of identifying inhibitory compounds and uses thereof
03/13/2003WO2002023190A3 Methods and products related to low molecular weight heparin
03/13/2003WO2002023188B1 Apparatus and method for detecting and classifying chemicals, particles, vira, and bacteria in fluids and air
03/13/2003WO2002022863A1 Method of diagnosing osteoporosis and/or estimating risk of osteoporosis fracture
03/13/2003WO2002020837A3 Method of nucleic acid typing or sequencing
03/13/2003WO2002020759A3 A non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
1 ... 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 2650 2651 2652 2653 2654 ... 3937